Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Derakhshan Behrad
Chief Business Officer at Edgewise Therapeutics. Filing since 2 May 2023.
CIK 0001853109
Company
Date
Role
Action
Shares
Amount
Of holding
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2026
Chief Business Officer
Sold at will
5,100
$223.42K
13.8%
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2025
Chief Business Officer
Sold at will
2,491
$33.36K
9.5%
EWTX
Edgewise Therapeutics, Inc.
2 May 2025
Chief Business Officer
Sold at will
1,691
$27.82K
7.7%
EWTX
Edgewise Therapeutics, Inc.
5 Feb 2025
Chief Business Officer
Sold at will
10,000
$300.30K
37.3%
EWTX
Edgewise Therapeutics, Inc.
20 Sep 2024
Chief Business Officer
Sold at will
42,068
$1.22M
73.6%
EWTX
Edgewise Therapeutics, Inc.
2 May 2024
Chief Business Officer
Sold at will
1,718
$32.49K
11.3%
EWTX
Edgewise Therapeutics, Inc.
9 Feb 2024
Chief Business Officer
Sold on a plan
4,800
$96.21K
40.6%
EWTX
Edgewise Therapeutics, Inc.
8 Feb 2024
Chief Business Officer
Sold on a plan
4,600
$92.05K
39.6%
EWTX
Edgewise Therapeutics, Inc.
7 Feb 2024
Chief Business Officer
Sold on a plan
600
$12.00K
7.9%
EWTX
Edgewise Therapeutics, Inc.
2 May 2023
Chief Business Officer
Sold at will
1,747
$15.56K
19.9%
10 decisions on file.
